(Q44113541)
Statements
1 reference
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion (English)
1 reference
Martin Rudwaleit
1 reference
Ignazio Olivieri
1 reference
Kyriaki A Boki
1 reference
Eduard N Griep
1 reference
Pentti Järvinen
1 reference
Robert L Wong
1 reference
Martina Kron
1 reference
Sonja Kary
1 reference
Hartmut Kupper
1 reference
1 March 2009
1 reference
1 reference
Identifiers
1 reference